Variant Summary
- HGVS
- —
- Variant Type(s)
- wild_type
- Evidence Items
- 6
Evidence Level Distribution
Level B: 4Level D: 2
Evidence Items
Showing CIViC evidence rows where gene = TP53 and variant = Wildtype.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Cancer | Rebemadlin | 4 |
| D | Predictive | Supports | Sensitivity/Response | Cancer | MDM2 Inhibitor AMGMDS3 | 4 |
| B | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Adjuvant Chemotherapy | 3 |
| B | Predictive | Supports | Sensitivity/Response | Leukemia | RG7112 | 3 |
| B | Predictive | Supports | Sensitivity/Response | Colorectal Cancer | Capecitabine,Cetuximab,Oxaliplatin | 3 |
| B | Predictive | Supports | Sensitivity/Response | Esophageal Carcinoma | Chemotherapy | 3 |